RESMED INC
Qualité des données : 100%
RSMDF
NYSE
Manufacturing
Measuring & Analyzing Instruments
24,89 €
0,00 €
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
12,64%
Croissance
Revenue Growth (5Y)
12,64%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)9,84%
Earnings (1Y)37,20%
FCF Growth (3Y)70,20%
Qualité
Return on Equity
23,88%
Au-dessus de la moyenne du secteur (-54,47%)
ROIC20,05%
Net Margin27,53%
Op. Margin33,70%
Sécurité
Debt / Equity
0,11
En dessous de la moyenne du secteur (0,30)
Current Ratio3,06
Interest CoverageN/A
Valorisation
PE (TTM|NTM)
19,28 | 60,71
Au-dessus de la moyenne du secteur (-1,49)
P/B Ratio4,53
EV/EBITDA13,78
Dividend Yield1,19%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 12,64% annually over 5 years — strong growth
Earnings grew 37,20% over the past year
ROE of 23,88% indicates high profitability
Net margin of 27,53% shows strong profitability
Debt/Equity of 0,11 — conservative balance sheet
Generating 1,79 B in free cash flow
Price History
Tendances Financières
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Growth
Rev 5Y: 12,64% · Earnings 1Y: 37,20%
Growth
Rev 5Y: 12,64% · Earnings 1Y: 37,20%| Revenue Growth (1Y) | 9,84% | Revenue Growth (3Y) | 10,39% |
| Earnings Growth (1Y) | 37,20% | Earnings Growth (3Y) | 24,92% |
| Revenue Growth (5Y) | 12,64% | Earnings Growth (5Y) | 31,08% |
Profitability
ROE: 23,88% · Net Margin: 27,53%
Profitability
ROE: 23,88% · Net Margin: 27,53%| Revenue (TTM) | 5,40 B | Net Income (TTM) | 1,49 B |
| ROE | 23,88% | ROA | 17,68% |
| Gross Margin | 60,87% | Operating Margin | 33,70% |
| Net Margin | 27,53% | Free Cash Flow (TTM) | 1,79 B |
| ROIC | 20,05% | FCF Growth (3Y) | 70,20% |
Safety
D/E: 0,11 · Current: 3,06
Safety
D/E: 0,11 · Current: 3,06| Debt / Equity | 0,11 | Current Ratio | 3,06 |
| Interest Coverage | N/A | Asset Turnover | 0,64 |
| Working Capital | 2,57 B | Tangible Book Value | 2,85 B |
Dividends
Yield: 1,19% · Payout: 2,30%
Dividends
Yield: 1,19% · Payout: 2,30%| Dividend Yield | 1,19% | Payout Ratio | 2,30% |
| Dividend Growth (3Y) | 9,53% | Dividend Growth (5Y) | 14,07% |
| Consecutive Div Years | 12 yrs | ||
Valuation
P/E: 19,28 · EV/EBITDA: 13,78
Valuation
P/E: 19,28 · EV/EBITDA: 13,78| P/E Ratio | 19,28 | Forward P/E | 60,71 |
| P/B Ratio | 4,53 | P/S Ratio | 5,31 |
| PEG Ratio | 0,62 | Forward PEG | N/A |
| EV/EBITDA | 13,78 | Fwd EV/EBITDA | N/A |
| Forward P/S | 4,72 | Fwd Earnings Yield | 1,65% |
| FCF Yield | 6,26% | ||
| Market Cap | 28,64 B | Enterprise Value | 27,89 B |
Per Share
EPS: 10,11 · FCF/Share: 1,23
Per Share
EPS: 10,11 · FCF/Share: 1,23| EPS (Diluted TTM) | 10,11 | Revenue / Share | 3,71 |
| FCF / Share | 1,23 | OCF / Share | 1,31 |
| EPS CAGR (1Y) | 37,43% | EPS CAGR (5Y) | 30,89% |
| EPS CAGR (10Y) | 16,06% | ||
Efficiency
FCF Conv: 120,58% · CapEx/Rev: 2,28%
Efficiency
FCF Conv: 120,58% · CapEx/Rev: 2,28%| CapEx / Revenue | 2,28% | FCF Conversion | 120,58% |
| SBC-Adj. FCF | 1,70 B | Growth Momentum | -2,80 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5,15 B | 4,69 B | 4,22 B | 3,58 B | 3,20 B |
| Net Income | 1,40 B | 1,02 B | 897,56 M | 779,44 M | 474,51 M |
| EPS (Diluted) | 9,51 | 6,92 | 6,09 | 5,30 | 3,24 |
| Gross Profit | 3,05 B | 2,66 B | 2,36 B | 2,02 B | 1,84 B |
| Operating Income | 1,69 B | 1,32 B | 1,13 B | 1,00 B | 903,68 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 331,28 M | 307,53 M | 287,64 M | 253,58 M | 225,28 M |
| SG&A Expenses | 991,02 M | 917,14 M | 874,00 M | 739,37 M | 670,39 M |
| D&A | 198,47 M | 176,87 M | 165,16 M | 159,61 M | 156,76 M |
| Interest Expense | — | — | -47,38 M | -22,31 M | 23,99 M |
| Income Tax | 276,84 M | 243,85 M | 204,11 M | 181,05 M | 409,16 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,17 B | 6,87 B | 6,75 B | 5,10 B | 4,73 B |
| Total Liabilities | 2,21 B | 2,01 B | 2,62 B | 1,74 B | 1,84 B |
| Shareholders' Equity | 5,97 B | 4,86 B | 4,13 B | 3,36 B | 2,89 B |
| Total Debt | 668,29 M | 707,21 M | 1,44 B | 775,24 M | 655,35 M |
| Cash & Equivalents | 1,21 B | 238,36 M | 227,89 M | 273,71 M | 295,28 M |
| Current Assets | 3,51 B | 2,36 B | 2,37 B | 1,93 B | 1,57 B |
| Current Liabilities | 1,02 B | 910,66 M | 758,53 M | 689,30 M | 911,77 M |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,3 | -1,5 |
| P/B | 4,5 | 1,6 |
| ROE % | 23,9 | -54,5 |
| Net Margin % | 27,5 | -41,5 |
| Rev Growth 5Y % | 12,6 | 1,8 |
| D/E | 0,1 | 0,3 |
Historique des dividendes
Historique des dividendes
Rendement
1,19%
Taux de distribution
2,30%
Croissance (3 ans)
9,53%
Croissance (5 ans)
14,07%
Derniers paiements par action (plus récent en premier).
| Ex-dividende | Paiement | Montant / action |
|---|---|---|
| Feb 11, 2026 | — | 0,06 € |
| Nov 12, 2025 | — | 0,06 € |
| Aug 13, 2025 | — | 0,06 € |
| May 07, 2025 | — | 0,05 € |
| Feb 12, 2025 | — | 0,05 € |
| Nov 06, 2024 | — | 0,05 € |
| Aug 14, 2024 | — | 0,05 € |
| May 08, 2024 | — | 0,05 € |
| Feb 07, 2024 | — | 0,05 € |
| Nov 08, 2023 | — | 0,05 € |
| Aug 16, 2023 | — | 0,05 € |
| May 10, 2023 | — | 0,04 € |
Scores de Stratégies
10 strategies matched
Scores de Stratégies
10 strategies matched
Custom
Mahmoud's Lower Risk
#12 of 21
Custom
Mahmoud's Lower Risk
#12 of 21
Custom
Saad's Balanced Risk
#30 of 40
Custom
Lower Risk (Copy)
#12 of 21
Growth
Cash Flow Compounder
#302 of 350
Growth
Capital Light Compounder
#55 of 85
#34 of 87
#23 of 27
Growth
Balanced Risk
#30 of 40
Growth
Lower Risk
#12 of 21
Activité Récente
Entré
Mahmoud's Lower Risk
Apr 12, 2026
Entré
Mahmoud's Lower Risk
Apr 12, 2026
Entré
Saad's Balanced Risk
Apr 12, 2026
Entré
Lower Risk (Copy)
Apr 12, 2026
Entré
Cash Flow Compounder
Apr 12, 2026
Entré
Capital Light Compounder
Apr 12, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Apr 12, 2026
Entré
Value Investing (Warren Buffett)
Apr 12, 2026
Entré
Balanced Risk
Apr 12, 2026
Entré
Lower Risk
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"RSMDF","listing_kind":"stock","pathname":"/stocks/rsmdf","exchange":"NYSE","country":"US"}}